「th」の検索結果
186件：81～85件目を表示
-
h 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Sh...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307.pdf -
h 7, 2025 General Announcement Senju Pharmaceutical Co., Ltd. Announcement of Licensing Agreement with Brill International Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Sh...
https://www.senju.co.jp/system/files/content_news/2025-03/ENG_20250307_0.pdf -
お知らせ | 千寿製薬株式会社
https://www.senju.co.jp/english/news/javascipt: void(0); -
harmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. Shuhei Yoshida) today announces that it has received approval for the marketing of “Mytear Lumify” (OTC drug requiring instruction b...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903.pdf -
R&D Pipeline | Research & Development | SENJU Pharmaceutica
PROGRESS OF DEVELOPMENT Disclosuring of information after Phase 1 DrugIndicationStatus (Region) SJP-0132Dry eyeLaunched（Japan） PranoprofeninflammationApplication under review (Vietnam) SJP-0132Dry eye
http://www.senju.co.jp/english/rd/pipeline.html